Moverman, Daniel J.
Liberman, Leslie D.
Kraemer, Stephan
Corfas, Gabriel
Liberman, M. Charles
Funding for this research was provided by:
National Institute on Deafness and Other Communication Disorders (R01 DC 00188)
Article History
Received: 25 August 2023
Accepted: 6 November 2023
First Online: 9 November 2023
Competing interests
: MCL and GC are scientific founders of Decibel Therapeutics and have received compensation for consulting. The company was not involved in this study. No other authors have any competing interest to declare.